Patents by Inventor Ulla Ribel-Madsen

Ulla Ribel-Madsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11167035
    Abstract: The invention is related to insulin compositions with a high content of zinc atoms per six molecules of acylated insulin. The insulin is an acylated insulin and may be mixed with a further insulin analogue such as the rapid acting insulin Asp B28 human insulin.
    Type: Grant
    Filed: July 16, 2014
    Date of Patent: November 9, 2021
    Assignee: Novo Nordisk A/S
    Inventors: Svend Havelund, Frantisek Hubalek, Helle Birk Olsen, Ib Jonassen, Thomas Hoeg-Jensen, Anne Plum, Ulla Ribel-Madsen
  • Publication number: 20210024604
    Abstract: The novel insulin derivates delivers, after administration to humans, insulin as a function of the glucose concentration in the tissue.
    Type: Application
    Filed: October 7, 2020
    Publication date: January 28, 2021
    Inventors: Thomas Hoeg-Jensen, Palle Jakobsen, Ulrich Sensfuss, Christian Fledelius, Ulla Ribel-Madsen
  • Publication number: 20200172593
    Abstract: The novel insulin derivates delivers, after administration to humans, insulin as a function of the glucose concentration in the tissue.
    Type: Application
    Filed: February 7, 2020
    Publication date: June 4, 2020
    Inventors: Thomas Hoeg-Jensen, Palle Jakobsen, Ulrich Sensfuss, Christian Fledelius, Ulla Ribel-Madsen
  • Publication number: 20180371045
    Abstract: The novel insulin derivates delivers, after administration to humans, insulin as a function of the glucose concentration in the tissue.
    Type: Application
    Filed: July 20, 2018
    Publication date: December 27, 2018
    Inventors: Thomas Hoeg-Jensen, Palle Jakobsen, Ulrich Sensfuss, Christian Fledelius, Ulla Ribel-Madsen
  • Patent number: 9889258
    Abstract: A drug delivery assembly includes a housing (110), a piston (120) axially displaceable in the housing, and a variable volume reservoir (105) formed by the housing and the piston and containing a fluid first drug. The assembly further includes an exterior fluid inlet (150) arranged in or configured to be arranged in fluid communication with the reservoir, a fluid outlet (145) arranged in or configured to be arranged in fluid communication with the reservoir, biasing means (130) configured for moving the piston forwards, and releasable retaining means (113) configured for retaining the piston in an initial position, whereby the biasing means is allowed to move the piston forwards to expel fluid drug from the reservoir when the retaining means is released.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: February 13, 2018
    Assignee: Novo Nordisk A/S
    Inventors: Henrik Bengtsson, Jonas K. Pedersen, Rikke B. Andersen, Jeppe Sturis, Kezia A. Juul, Lars Eilertsen, Ulla Ribel-Madsen
  • Publication number: 20160229902
    Abstract: The novel insulin derivates delivers, after administration to humans, insulin as a function of the glucose concentration in the tissue.
    Type: Application
    Filed: April 18, 2016
    Publication date: August 11, 2016
    Inventors: Thomas Hoeg-Jensen, Palle Jakobsen, Ulrich Sensfuss, Christian Fledelius, Ulla Ribel-Madsen
  • Publication number: 20150182595
    Abstract: Insulin preparations comprising an insulin compound or a mixture of two or more insulin compounds, a nicotinic compound and an amino acid.
    Type: Application
    Filed: March 16, 2015
    Publication date: July 2, 2015
    Inventors: Helle Birk Olsen, Svend Havelund, Ulla Ribel-Madsen, Jeppe Sturis, Helle Naver, Morten Schlein, Svend Ludvigsen
  • Patent number: 9018161
    Abstract: The present invention relates to novel insulin analogues exhibiting resistance towards protease, wherein at least two amino acids are substituted and/or deleted relative to the parent insulin molecule. A method for the preparation of such insulin analogues, insulin preparations containing the insulin analogues of the invention and a method of treating diabetes mellitus using these insulin analogues is also provided.
    Type: Grant
    Filed: September 20, 2007
    Date of Patent: April 28, 2015
    Assignee: Novo Nordisk A/S
    Inventors: Peter Kresten Nielsen, Frantisek Hubalek, Inger Lautrup-Larsen, Svend Ludvigsen, Ulla Ribel-Madsen, Per Balschmidt, Per Nørgaard, Svend Havelund
  • Publication number: 20140349925
    Abstract: The present invention relates to insulin derivatives which are naturally occurring insulins or analogues thereof which have a side chain attached either to the ?-amino group of the N-terminal amino acid residue of the B chain or to the ?-amino group of a Lys residue present in the B chain of the parent insulin, the side chain being of the general formula: —W—X—Y—Z wherein W, X, Y and Z are as defined in the disclosure.
    Type: Application
    Filed: August 6, 2014
    Publication date: November 27, 2014
    Inventors: Ib Jonassen, Thomas Hoeg-Jensen, Svend Havelund, Ulla Ribel-Madsen, Tina Moeller Tagmose, Peter Madsen
  • Publication number: 20140336586
    Abstract: A drug delivery assembly comprises a housing (110), a piston (120) axially displaceable in the housing, and a variable volume reservoir (105) formed by the housing and the piston and containing a fluid first drug. The assembly further comprises an exterior fluid inlet (150) arranged in or configured to be arranged in fluid communication with the reservoir, a fluid outlet (145) arranged in or configured to be arranged in fluid communication with the reservoir, biasing means (130) configured for moving the piston forwards, and releasable retaining means (113) configured for retaining the piston in an initial position, whereby the biasing means is allowed to move the piston forwards to expel fluid drug from the reservoir when the retaining means is released.
    Type: Application
    Filed: November 30, 2012
    Publication date: November 13, 2014
    Applicant: NOVO NORDISK A/S
    Inventors: Henrik Bengtsson, Jonas K. Pedersen, Rikke B. Andersen, Jeppe Sturis, Kezia A. Juul, Lars Eilertsen, Ulla Ribel-Madsen
  • Publication number: 20140328943
    Abstract: The invention is related to insulin compositions with a high content of zinc atoms per six molecules of acylated insulin. The insulin is an acylated insulin and may be mixed with a further insulin analogue such as the rapid acting insulin Asp B28 human insulin.
    Type: Application
    Filed: July 16, 2014
    Publication date: November 6, 2014
    Inventors: Svend Havelund, Frantisek Hubalek, Helle Birk Olsen, Ib Jonassen, Thomas Hoeg-Jensen, Anne Plum, Ulla Ribel-Madsen
  • Patent number: 8828923
    Abstract: The present invention relates to insulin derivatives which are naturally occurring insulins or analogues thereof which have a side chain attached either to the ?-amino group of the N-terminal amino acid residue of the B chain or to the ?-amino group of a Lys residue present in the B chain of the parent insulin, the side chain being of the general formula: —W—X—Y—Z wherein W, X, Y and Z are as defined in the disclosure.
    Type: Grant
    Filed: September 16, 2009
    Date of Patent: September 9, 2014
    Assignee: Novo Nordisk A/S
    Inventors: Ib Jonassen, Thomas Hoeg-Jensen, Svend Havelund, Ulla Ribel-Madsen, Tina Møller Tagmose, Peter Madsen
  • Publication number: 20140206610
    Abstract: Insulin preparations comprising an insulin compound or a mixture of two or more insulin compounds, a nicotinic compound and an amino acid.
    Type: Application
    Filed: March 24, 2014
    Publication date: July 24, 2014
    Applicant: Novo Nordisk A/S
    Inventors: Helle Birk Olsen, Svend Havelund, Ulla Ribel-Madsen, Jeppe Sturis, Helle Naver, Morten Schlein, Svend Ludvigsen
  • Publication number: 20130331320
    Abstract: Insulin preparations comprising a long-acting insulin compound, a fast-acting insulin compound, a nicotinic compound and an amino acid.
    Type: Application
    Filed: December 14, 2011
    Publication date: December 12, 2013
    Applicant: Novo Nordisk A/S
    Inventors: Svend Havelund, Ulla Ribel-Madsen, Ib Jonassen, Helle Birk Olsen
  • Patent number: 8324157
    Abstract: Insulin preparations comprising an insulin compound or a mixture of two or more insulin compounds, a nicotinic compound and an amino acid.
    Type: Grant
    Filed: December 1, 2011
    Date of Patent: December 4, 2012
    Assignee: Novo Nordisk A/S
    Inventors: Helle Birk Olsen, Svend Havelund, Ulla Ribel-Madsen, Jeppe Sturis, Helle Naver, Morten Schlein, Svend Ludvigsen
  • Publication number: 20120184487
    Abstract: The novel insulin derivates delivers, after administration to humans, insulin as a function of the glucose concentration in the tissue.
    Type: Application
    Filed: June 29, 2010
    Publication date: July 19, 2012
    Applicant: Novo Nordisk A/S
    Inventors: Thomas Hoeg-Jensen, Palle Jakobsen, Ulrich Sensfuss, Christian Fledelius, Ulla Ribel-Madsen
  • Publication number: 20120135920
    Abstract: Insulin preparations comprising an insulin compound or a mixture of two or more insulin compounds, a nicotinic compound and an amino acid.
    Type: Application
    Filed: December 1, 2011
    Publication date: May 31, 2012
    Applicant: Novo Nordisk A/S
    Inventors: Helle Birk Olsen, Svend Havelund, Ulla Ribel-Madsen, Jeppe Sturis, Helle Naver, Morten Schlein, Svend Ludvigsen
  • Publication number: 20110245163
    Abstract: The present invention relates to human insulin analogues having a fast onset of action. These analogues may have amino acid in position B26 substituted with Phe, or be Des(B30) analogues of human insulin. The invention also relates to compositions comprising such insulin analogues, and to compositions comprising a mixture of an insulin analogue having a fast onset of action and insulin having a protracted action.
    Type: Application
    Filed: April 5, 2011
    Publication date: October 6, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Ib Jonassen, Sven Havelund, Thomas Børglund Kjeldsen, Ulla Ribel-Madsen
  • Publication number: 20100009899
    Abstract: The present invention relates to insulin derivatives which are naturally occurring insulins or analogues thereof which have a side chain attached either to the ?-amino group of the N-terminal amino acid residue of the B chain or to the ?-amino group of a Lys residue present in the B chain of the parent insulin, the side chain being of the general formula: —W—X—Y—Z wherein W, X, Y and Z are as defined in the disclosure.
    Type: Application
    Filed: September 16, 2009
    Publication date: January 14, 2010
    Applicant: Novo Nordisk A/S
    Inventors: Ib Jonassen, Thomas Hoeg-Jensen, Svend Havelund, Ulla Ribel-Madsen, Tina Møller Tagmose, Peter Madsen
  • Publication number: 20100009898
    Abstract: The present invention relates to novel insulin analogues exhibiting resistance towards protease, wherein at least two amino acids are substituted and/or deleted relative to the parent insulin molecule. A method for the preparation of such insulin analogues, insulin preparations containing the insulin analogues of the invention and a method of treating diabetes mellitus using these insulin analogues is also provided.
    Type: Application
    Filed: September 20, 2007
    Publication date: January 14, 2010
    Inventors: Peter Kresten Nielsen, Frantisek Hubalek, Inger Lautrup-Larsen, Svend Ludvigsen, Ulla Ribel-Madsen, Per Balschmidt, Per Norgaard, Svend Havelund